H.R. 5269 119th Congress
RESULTS Act
Latest action, Sep 10, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
How the House voted
The House hasn't taken a roll call on this bill in the Congresses covered.
129 cosponsors
Sponsored by Richard Hudson (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
- Democrat
- Republican
- Independent
Referred to: House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
The top 25 of 50 clients, by reports
| Client | Lobbying firm | Reports | Reports totaling | From | To | House |
|---|---|---|---|---|---|---|
| ADVANCED MEDICAL TECHNOLOGY ASSN | 5 | $5.0M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN ACADEMY OF FAMILY PHYSICIANS | 5 | $3.7M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN ASSOCIATION OF BIOANALYSTS | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 5 | $350K | Q4 2025 | Q3 2026 | yes |
| AMERICAN SOCIETY FOR HISTOCOMPATIBILITY AND IMMUNOGENETICS | WHEAT SHROYER GOVERNMENT RELATIONS LLC | 5 | $100K | Q4 2025 | Q3 2026 | yes |
| ARUP LABORATORIES, INC. | VAN SCOYOC ASSOCIATES | 5 | $150K | Q4 2025 | Q3 2026 | yes |
| BIOMERIEUX, INC. | ALSTON & BIRD LLP | 5 | $0 | Q4 2025 | Q3 2026 | yes |
| COLLEGE OF AMERICAN PATHOLOGISTS | 5 | $968K | Q4 2025 | Q3 2026 | yes | |
| DH DIAGNOSTICS LLC | TIBER CREEK GROUP | 5 | $0 | Q4 2025 | Q3 2026 | yes |
| DH DIAGNOSTICS, LLC | 5 | $1.3M | Q4 2025 | Q3 2026 | yes | |
| F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES | 5 | $520K | Q4 2025 | Q3 2026 | yes | |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | KELLEY DRYE & WARREN LLP | 5 | $0 | Q4 2025 | Q3 2026 | yes |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | 5 | $2.0M | Q4 2025 | Q3 2026 | yes | |
| QUEST DIAGNOSTICS INCORPORATED | 5 | $2.1M | Q4 2025 | Q3 2026 | yes | |
| QUEST DIAGNOSTICS INCORPORATED | FEDERAL STREET STRATEGIES, LLC | 5 | $0 | Q4 2025 | Q3 2026 | yes |
| SIEMENS MEDICAL SOLUTIONS USA, INC | 5 | $3.3M | Q4 2025 | Q3 2026 | yes | |
| THERMO FISHER SCIENTIFIC INC | 5 | $2.4M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | 4 | $7.7M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN CLINICAL LABORATORY ASSN | 4 | $3.3M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN HOSPITAL ASSOCIATION | 4 | $21.0M | Q4 2025 | Q3 2026 | yes | |
| ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 4 | $280K | Q4 2025 | Q3 2026 | yes | |
| ASSOCIATION FOR MOLECULAR PATHOLOGY | IPOLICY SOLUTIONS | 4 | $282K | Q4 2025 | Q3 2026 | yes |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 4 | $2.5M | Q4 2025 | Q3 2026 | yes | |
| CAREDX, INC. | TODD STRATEGY GROUP | 4 | $0 | Q4 2025 | Q2 2026 | yes |
| CHRONIC CARE POLICY ALLIANCE | 4 | $40K | Q4 2025 | Q3 2026 | yes | |
| HEALTHCARE INSTITUTE OF NEW JERSEY | 4 | $187K | Q4 2025 | Q3 2026 | yes |